Data as of Jul 28
| -0.16 / -2.27%|
The 5 analysts offering 12-month price forecasts for Spectrum Pharmaceuticals Inc have a median target of 15.00, with a high estimate of 15.00 and a low estimate of 7.50. The median estimate represents a +117.71% increase from the last price of 6.89.
The current consensus among 5 polled investment analysts is to Buy stock in Spectrum Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.